WASHINGTON — A massive recall of millions of sleep apnea machines has stoked anger and frustration among patients, and U.S. officials are weighing unprecedented legal action to speed a replacement effort that is set to drag into next year.
While drone delivery service has had a foothold for years in numerous international locations, a stringent U.S. federal regulatory system has contributed to a lag in adopting the new technology domestically, and Intermountain’s program is the first of its kind west of the Mississippi, according to program officials.
Assume our business is always about the patient. That was how Michael Schmidt, co-founder and executive board member of Tenthpin Management Consultants, introduced a panel of clinical supply chain experts who shared their thoughts about where the industry was headed during a recent SAP life sciences event. Their conversation reflected the future of life sciences as they discussed their experiences getting closer to partners, gaining clinical supply chain efficiencies, and extracting business results from technology investments.
President Joe Biden is launching a new initiative to encourage biotech production and research in the U.S., the latest move by the White House to boost domestic industry.
Like virtually every other business, hospitals are contending with unusual cost and operational pressures. According to recent data released this month by health management consulting firm Kaufman Hall, hospitals and health systems are spending 19% more on drugs, 18% more on supplies and 21% more on labor compared to two years ago. A great many are also facing persistent workforce, supply-chain and other economic concerns.